81 Most studies have evaluated monotherapeutic agonists
A retrospective analysis of a national medical records database (2017/2018, n = 473 patients) revealed that 40% of women with IPTB delivered within 48 h, justifying the initial NAC iv -infusion for the severe IPTB subgroup to maximize efficacy, due to NACs rapid placental transfer
Intellias NTLA-2001, being developed along with partner Regeneron for the genetic liver disease transthyretin (ATTR) amyloidosis cardiomyopathy, is expected to enter Phase III by the end of this year, Intellia announced
Reclining chairs and a quiet space are important , but the priority should be licensed care, ingredient transparency and clear communication about risks
Hornig M, Gottschalk CG, Eddy ML, Che X, Ukaigwe JE, Peterson DL, et al